Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

Similar articles for PubMed (Select 18055234)

1.

Tumor necrosis factor-alpha and interleukin-6 are not correlated with the characteristics of Complex Regional Pain Syndrome type 1 in 66 patients.

Wesseldijk F, Huygen FJ, Heijmans-Antonissen C, Niehof SP, Zijlstra FJ.

Eur J Pain. 2008 Aug;12(6):716-21. Epub 2007 Dec 4.

PMID:
18055234
2.

Bilateral complex regional pain syndrome in a woman with major depressive disorder.

Dormohammadi Toosi T, Karimpour Reihan S, Afshari A, Naderi N, Shahbazi F, Khalvat A.

Arch Iran Med. 2015 Mar;18(3):196-8. doi: 0151803/AIM.0012.

3.

A suction blister model reliably assesses skin barrier restoration and immune response.

Smith TJ, Wilson MA, Young AJ, Montain SJ.

J Immunol Methods. 2015 Feb;417:124-30. doi: 10.1016/j.jim.2015.01.002. Epub 2015 Jan 10.

PMID:
25585263
4.

Activation of cutaneous immune responses in complex regional pain syndrome.

Birklein F, Drummond PD, Li W, Schlereth T, Albrecht N, Finch PM, Dawson LF, Clark JD, Kingery WS.

J Pain. 2014 May;15(5):485-95. doi: 10.1016/j.jpain.2014.01.490. Epub 2014 Jan 23.

5.

The association of pain with protein inflammatory biomarkers: a review of the literature.

DeVon HA, Piano MR, Rosenfeld AG, Hoppensteadt DA.

Nurs Res. 2014 Jan-Feb;63(1):51-62. doi: 10.1097/NNR.0000000000000013. Review.

PMID:
24335913
6.

Inflammatory processes in complex regional pain syndromes.

Hauser J, Hsu B, Nader ND.

Immunol Invest. 2013;42(4):263-72. doi: 10.3109/08820139.2013.764317. Review.

PMID:
23883195
7.

Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months.

Lenz M, Uçeyler N, Frettlöh J, Höffken O, Krumova EK, Lissek S, Reinersmann A, Sommer C, Stude P, Waaga-Gasser AM, Tegenthoff M, Maier C.

Pain. 2013 Oct;154(10):2142-9. doi: 10.1016/j.pain.2013.06.039. Epub 2013 Jun 27.

PMID:
23811041
8.

Diagnosis of partial complex regional pain syndrome type 1 of the hand: retrospective study of 16 cases and literature review.

Konzelmann M, Deriaz O, Luthi F.

BMC Neurol. 2013 Mar 18;13:28. doi: 10.1186/1471-2377-13-28. Review.

9.

Targeting oxidative injury and cytokines' activity in the treatment with anti-tumor necrosis factor-α antibody for complex regional pain syndrome 1.

Miclescu AA, Nordquist L, Hysing EB, Butler S, Basu S, Lind AL, Gordh T.

Pain Pract. 2013 Nov;13(8):641-8. doi: 10.1111/papr.12027. Epub 2013 Jan 21.

PMID:
23336526
10.

Proinflammatory cytokine levels in saliva in patients with burning mouth syndrome before and after treatment with low-level laser therapy.

Pezelj-Ribarić S, Kqiku L, Brumini G, Urek MM, Antonić R, Kuiš D, Glažar I, Städtler P.

Lasers Med Sci. 2013 Jan;28(1):297-301. doi: 10.1007/s10103-012-1149-5. Epub 2012 Jul 8.

PMID:
22773117
11.

Demographic and medical parameters in the development of complex regional pain syndrome type 1 (CRPS1): prospective study on 596 patients with a fracture.

Beerthuizen A, Stronks DL, Van't Spijker A, Yaksh A, Hanraets BM, Klein J, Huygen FJ.

Pain. 2012 Jun;153(6):1187-92. doi: 10.1016/j.pain.2012.01.026. Epub 2012 Mar 3.

PMID:
22386473
12.

Implications of a local overproduction of tumor necrosis factor-α in complex regional pain syndrome.

Walker S, Drummond PD.

Pain Med. 2011 Dec;12(12):1784-807. doi: 10.1111/j.1526-4637.2011.01273.x. Epub 2011 Nov 14. Review.

PMID:
22082181
13.

Study on the T-helper cell 1/2 cytokine profile in blister fluid of patients with herpes zoster and its clinical significance.

Zhang M, Wu N, Yang L, Zhang J, Sun X, Zhong S, Ma X, Wang Y.

J Dermatol. 2011 Dec;38(12):1158-62. doi: 10.1111/j.1346-8138.2011.01289.x. Epub 2011 Sep 29.

PMID:
21954956
14.

[Malonaldehyde and tumor necrosis factor-alpha as indicators of intoxication syndrome in erysipelatous inflammation].

Marzhokhova MIu, Afashagova MM, Marzhokhova AR.

Klin Lab Diagn. 2011 May;(5):20-2. Russian.

PMID:
21789799
15.

The association between psychological factors and the development of complex regional pain syndrome type 1 (CRPS1)--a prospective multicenter study.

Beerthuizen A, Stronks DL, Huygen FJ, Passchier J, Klein J, Spijker AV.

Eur J Pain. 2011 Oct;15(9):971-5. doi: 10.1016/j.ejpain.2011.02.008. Epub 2011 Apr 2.

PMID:
21459637
16.

Cytokine imbalance/activity as a unifying hypothesis for the pathogenesis and pathophysiology of Complex Regional Pain Syndrome?

Harden RN.

Pain. 2011 Feb;152(2):247-8. doi: 10.1016/j.pain.2010.10.019. Epub 2010 Nov 30. No abstract available.

PMID:
21122995
17.

Multiple interventions for treating chronic inflammation in older adults: what is the best strategy?

Cornish SM, Chilibeck PD.

Exerc Sport Sci Rev. 2010 Apr;38(2):99. doi: 10.1097/JES.0b013e3181d49707. No abstract available.

PMID:
20335742
18.

Inflammatory consequences of cutaneous stimulation.

Drummond PD.

Exp Neurol. 2010 Apr;222(2):181-3. doi: 10.1016/j.expneurol.2010.01.012. Epub 2010 Jan 25. No abstract available.

PMID:
20109447
19.

Complex regional pain syndrome type 1 may be associated with menstrual cycle disorders: a case-control study.

van den Berg I, Liem YS, Wesseldijk F, Zijlstra FJ, Hunink MG.

Complement Ther Med. 2009 Oct-Dec;17(5-6):262-8. doi: 10.1016/j.ctim.2009.09.003. Epub 2009 Nov 7.

PMID:
19942105
20.

The first scintigraphic detection of tumor necrosis factor-alpha in patients with complex regional pain syndrome type 1.

Bernateck M, Karst M, Gratz KF, Meyer GJ, Fischer MJ, Knapp WH, Koppert W, Brunkhorst T.

Anesth Analg. 2010 Jan 1;110(1):211-5. doi: 10.1213/ANE.0b013e3181c4bab7. Epub 2009 Nov 12.

PMID:
19910617
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk